{"id":"azacitidine-injection-vidaza","safety":{"commonSideEffects":[{"rate":"34%","effect":"Fatigue"},{"rate":"31%","effect":"Nausea"},{"rate":"28%","effect":"Diarrhea"},{"rate":"26%","effect":"Pyrexia"},{"rate":"24%","effect":"Cough"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Azacitidine is a hypomethylating agent that works by inhibiting DNA methyltransferase, leading to a decrease in DNA methylation and an increase in gene expression.","oneSentence":"Inhibits DNA methyltransferase","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:30:19.322Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myeloid leukemia"},{"name":"Mylodysplastic syndromes"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Azacitidine Injection [Vidaza]","genericName":"Azacitidine Injection [Vidaza]","companyName":"Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias","companyId":"grupo-cooperativo-de-estudio-y-tratamiento-de-las-leucemias-agudas-y-mielodispla","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inhibits DNA methyltransferase Used for Acute myeloid leukemia, Mylodysplastic syndromes.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}